Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 4

3(42.9%)

Phase 1

1(14.3%)

7Total

N/A(3)

Phase 4(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01313533Phase 1Unknown

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

Role: lead

NCT02951702Phase 4Completed

Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics

Role: lead

NCT02232958Not ApplicableTerminated

Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease

Role: lead

NCT02890888Not ApplicableTerminated

Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease

Role: lead

NCT01159652Phase 4Completed

Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

Role: lead

NCT00497432Completed

Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities

Role: lead

NCT00901771Not ApplicableCompleted

Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP

Role: lead

NCT00506974Phase 4Completed

Enhancing Slow Wave Sleep With Sodium Oxybate

Role: lead

All 8 trials loaded